Communicable Diseases
22
2
3
17
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 22 trials
100.0%
+13.5% vs benchmark
14%
3 trials in Phase 3/4
24%
4 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (22)
Establishment of a Biobank for the Evaluation of Rapid Diagnostic Solutions
SAFE Workplace Intervention for People With IDD
Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children
Comparative Autoantibody and Immunologic Cell Marker Study
Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
Collection of Plasma From People Who Recovered From or Were Vaccinated to Emerging Infectious Diseases
NASCITA Italian Birth Cohort Study
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)
Mapping the Health Status of the Population of French Polynesia: the MATAEA Project
Opinion of the Infectious Disease Specialist Referent for the Good Use of AnTiBiotics
A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses
Probiotics to Promote Intestinal Health
Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection
Computerized Antibiotic Stewardship Study
Reducing Delay of Vaccination in Children Study
Vaccine Social Media Randomized Intervention Trial
Automatic Chlorination and Child Health in Urban Bangladesh
Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Snow Disease Surveillance System Study
Epidemiology of H. Pylori Transmission